Michael Quirmbach

Michael Quirmbach is the CEO of Corden Pharma, a contract manufacturer based in Basel, Switzerland. He has been navigating the challenges posed by increasing demand from clients for U.S.-based production capabilities, as many pharmaceutical companies seek to mitigate risks associated with tariffs. Quirmbach is also focused on expanding Corden's manufacturing capacity in Colorado to meet the growing demand for specific drug preparations.